Nalaganje...
Recent advances in the first-line treatment of follicular non-Hodgkin lymphoma
Follicular lymphoma (FL) is the most common type of indolent B-cell lymphoma. Twenty years ago, FL was considered an indolent lymphoma with a long survival time but without a high rate of complete remission with chemotherapies. The use of rituximab has improved the response and survival of patients...
Shranjeno v:
| izdano v: | F1000Res |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
F1000 Research Limited
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6426075/ https://ncbi.nlm.nih.gov/pubmed/30906531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.16686.1 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|